Another cohort study of 163 patients with CKD stages I–V and 82 healthy volunteers also demonstrated that serum NGAL levels are significantly higher in CKD group than healthy group (AvciÇiçek et al., 2016). This evidence concerns the gene LCN2 and chronic kidney disease.